Drug Profile
Amsilarotene
Alternative Names: Am-555S; TAC-101Latest Information Update: 23 Sep 2021
Price :
$50
*
At a glance
- Originator Taiho Pharmaceutical
- Class Antineoplastics; Benzoic acids; Retinoids; Small molecules
- Mechanism of Action Angiogenesis inhibitors; Retinoic acid receptor alpha antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Liver cancer
Most Recent Events
- 17 Mar 2011 Discontinued - Phase-II for liver cancer in Italy (PO)
- 17 Mar 2011 Discontinued - Phase-II for liver cancer in Japan (PO)
- 22 Jul 2009 Suspended - Phase-II for liver cancer in Japan (PO)